期刊文献+

骨桥蛋白反义寡核苷酸对微缺氧下人结肠癌细胞HT-29体外侵袭游走能力的影响 被引量:4

Effects of antisense oligonucleotide targeting osteopontin on invasion and metastasis of colon carcinoma cell line HT-29 in vitro under moderate hypoxia
原文传递
导出
摘要 目的观察靶向骨桥蛋白(OPN)的反义寡核苷酸(ASODN)对微缺氧下HT-29细胞侵袭转移潜能等的影响,探讨OPN与微缺氧诱导的肿瘤恶性表型的关系。方法合成ASODN,以Lipofectamine为载体,将其转染入微缺氧下高表达OPN的HT-29细胞。RT—PCR和Western blot分别检测转染细胞微缺氧下OPN mRNA和蛋白的表达;Transwell侵袭试验判定其侵袭游走能力;明胶酶谱分析检测分泌的MMP-2/9活性变化。结果微缺氧诱导的OPN mRNA和蛋白表达被靶向OPN的ASODN特异性地抑制,表达量分别是对照组的31.5%和35.4%。ASODN组HT-29细胞穿过微孔膜的细胞数仅为(52.6±3.8)个;明胶酶活性下降71%,与各对照组比较,差异有统计学意义(P〈0.01)。结论靶向OPN的ASODN明显抑制微缺氧诱导的OPN mRNA和蛋白表达,并显著下调微缺氧诱导的细胞分泌MMP2/9的活性及其侵袭游走能力。OPN在微缺氧促进肿瘤向恶性表型转化中起着重要作用。 Objective To study the effects of antisense oligonucleotide (ASODN) targeting osteopontin on the invasion of HT-29 cells under moderate hypoxia, and investigate correlation between osteopontin and malignant phenotype induced by moderate hypoxia. Methods ASODN targeting osteopontin was synthesized with a phosphorothioate backbone. By Lipofectamine, ASODN was transfected into HT-29 cells with high expression of osteopontin induced by moderate hypoxia. The osteopontin mRNA and protein levels in HT-29 cells transfected with ASODN were detected by RT-PCR and Western blot respectively. Reaction to a hypoxic environment was determined via invasion across a Matrigel-coated Transwell filter. The activity of MMP-2 and MMP-9 was assessed using gelatin zymography. Results ASODN targeting osteopontin could selectively and significantly down-regulate the levels of osteopontin mRNA and protein, with 31.5% and 35.4% of the controls respectively. The number of HT-29 cells migrating to the micro- porous membrane in ASODN group was only 52.6 _+ 3.8. ASODN targeting osteopontin could suppress significantly the MMP2/9 activities down to 71% in HT-29 cells exposed to moderate hypoxia. Conclusion ASODN targeting osteopontin could down-regulate the osteopontin mRNA and protein levels in HT-29 cells exposed to moderate hypoxia. The invasive capacity and MMP2/9 activities previously induced by moderate hypoxia could be inhibited when osteopontin was suppressed by ASODN. It suggested that osteopontin might play a key role in malignant phenotype when HT-29 ceils were exposed to moderate hypoxia.
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2009年第9期1163-1165,共3页 Chinese Journal of Experimental Surgery
关键词 结肠癌 反义寡核苷酸 骨桥蛋白 恶性表型 Colon carcinoma Antisense oligonucleotide Osteopontin Malignant phenotype
  • 相关文献

参考文献5

二级参考文献7

  • 1黄耿文,杨连粤,鲁伟群,杨建青,刘合利.VEGF、HIF-1 alpha、EGF在肝细胞癌中的表达及其临床意义[J].中华普通外科杂志,2004,19(6):358-360. 被引量:8
  • 2夏曙,于世英,袁响林,付向宁.非小细胞肺癌中HIF-1α蛋白的表达与多药耐药蛋白相关性的研究[J].中华实验外科杂志,2004,21(12):1515-1517. 被引量:10
  • 3Russo A, Bazan V, Migliavacca M, et al. DNA aneuploidy and high proliferative activity but not K-ras-2 mutations as independent predictors of clinical outcome in operable gastric carcinoma:results of a 5-year gruppo oncdogico dell italia meridonale (GDIM) prospective study. Cancer,2001,92:294-302.
  • 4Vol M, Koomagi R, Stammler G, et al. Prognostic implications of cyclin (D1, E, A), cyclin-dependent kinases ( CDK2, CDK4) and tumor suppressor gene (pRBP16INK4A) in childhood acute lymphoblastic leukemia. Int J Cancer, 1997,74 : 508-511.
  • 5Friberg LG, Noren H, Delle U, et al. Prognostic value of DNA ploidy and S-phase fraction in endometrial cancer stage Ⅰ and Ⅱ :a prospective 5-years survival study. Gynecol Oncol, 1994,53 : 64-66.
  • 6Fukuda R, Hirota K, Fan F, et al. Insulin-like growth factor 1 induces hypoxia-inducible factor 1-mediated vascular endothelial growth factor expression,which is dependent on MAP kinase and phosphatidylinositol 3-kinasc signaling in colon cancer cells. J Biol Chcm, 2002,277 : 38205-38211.
  • 7Paul F, Paul Z, Nawar A, et al. Hypoxia augments gelatinase activity in a variety of adenocarcinomas in vitro. Journal of Surgical Research, 2005,124 : 180-186.

共引文献18

同被引文献18

  • 1程宝春,胡向阳,程宏伟,杨风,万经海,冯春国,李长元.骨桥蛋白在脑胶质瘤中的表达及与其预后的关系[J].中华实验外科杂志,2005,22(9):1140-1140. 被引量:7
  • 2陈荣新,薛同春,叶胜龙,孙瑞霞,赵燕,汤钊猷.骨桥蛋白促进人肝癌细胞株SMMC-7721肿瘤转移相关基因改变的研究[J].中华实验外科杂志,2006,23(8):943-944. 被引量:12
  • 3Zheng L,Jaffee EM.Annexin A2 is a new antigenic target for pancre-atic cancer immunotherapy.Oncoimmunology,2012,1:112-114.
  • 4Madureira PA,Hill R,Miller VA,et al.Annexin A2 is a novel cellularredox regulatory protein involved in tumorigenesis.Oncotarget,2011,2:1075-1093.
  • 5Liang QL,Chen GQ,Li ZY,et al.Function and histopathology of a celladhesion molecule TSLCl in cancer.Cancer Invest,2011,29:107-112.
  • 6Liu QL, Liang QL, Li ZY, et al. Function and expression of prolyl hydroxylase 3 in cancers. Arch Med Sci,2013,9:589-593.
  • 7Zheng L,Jaffee EM. Annexin A2 is a new antigenic target for pancre- atic cancer immunotherapy. Oncoimmunology ,2012,1 : 112-114.
  • 8Madureira PA, Hill R, Miller VA, et al. Annexin A2 is a novel cellular redox regulatory protein involved in tumorigenesis. Oncotarget, 2011, 2 : 1075-1093.
  • 9Liang QL,Chen GQ,Li ZY,et al. Function and histopathology of a cell adhesion molecule TSLC1 in cancer. Cancer Invest, 2011,29: 107- 112.
  • 10Shi H,Ji M,Wu J,et al.Serum B7-H4 expression is a significant prognostic indicator for patients with gastric cancer[J].World J Surg 0ncol,2014,12:188.

引证文献4

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部